Development and Validation of a Cellulitis Risk Score: The Melbourne ASSET Score
Laila F Ibrahim, Sandy M Hopper, Susan Donath, Bennett Salvin, Franz E Babl, Penelope A Bryant
PEDIATRICS | AMER ACAD PEDIATRICS | Published : 2019
: media-1vid110.1542/5972298232001PEDS-VA_2018-1420Video Abstract BACKGROUND: The evidence is unclear about the optimal route of treatment for children with cellulitis, specifically how to assess the risk of moderate-to-severe cellulitis requiring intravenous (IV) antibiotics. We aimed to derive and validate a cellulitis risk assessment scoring system to guide providers as to which patients require IV antibiotics. METHODS: This was a prospective cohort study of children presenting to the emergency department aged 6 months to 18 years diagnosed with cellulitis from January 2014 to August 2017. Patients were divided into 2 groups based on route of antibiotics at 24 hours (the predetermined gol..View full abstract
Funded in part by grants from The Royal Children's Hospital Foundation, the Murdoch Children's Research Institute, and the Victorian Department of Health and Human Services in Melbourne, Australia. Ms Ibrahim was supported in part by a scholarship from Avant Mutual Group Ltd (Melbourne), the Melbourne Children's Campus Postgraduate Health Research Scholarship, and the Doctor Nicholas Collins Fellowship. Dr Bryant was supported in part by a Melbourne Campus Clinician Scientist Fellowship (Melbourne, Australia). Dr Babl was supported in part by a grant from The Royal Children's Hospital Foundation, a Melbourne Campus Clinician Scientist Fellowship (Melbourne, Australia), and a National Health and Medical Research Council Practitioner's Fellowship (Canberra, Australia). The Emergency Research Group at Murdoch Children's Research Institute is supported in part by a National Health and Medical Research Council Centre for Research Excellence grant for pediatric emergency medicine (Canberra, Australia) and the Victorian government's Operational Infrastructure Support Program. The funding bodies do not have any authority in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.